Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Lerman

Showing results (241-250 of 245) with videos related to

Pageof 25
Sort By:
You have reached the last page of results.This site can display upto 245 results.
JAMA|June 26, 1996
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomesC Lerman, S Narod, K Schulman, et al.
British Journal of Cancer|September 16, 1999
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutationsS Wang-Gohrke, W Weikel, H Risch, et al.
Journal of the National Cancer Institute|May 30, 1998
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genesJ S Brunet, P Ghadirian, T R Rebbeck, et al.
Pharmacogenetics|October 23, 2001
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptivesI B Runnebaum, S Wang-Gohrke, D Vesprini, et al.
Nature Medicine|November 1, 1996
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer familiesP Tonin, B Weber, K Offit, et al.
Pageof 25

Showing results (241-250 of 245) with videos related to

Sort By:
Pageof 25
You have reached the last page of results.This site can display upto 245 results.
JAMA|June 26, 1996
BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomesC Lerman, S Narod, K Schulman, et al.
British Journal of Cancer|September 16, 1999
Intron variants of the p53 gene are associated with increased risk for ovarian cancer but not in carriers of BRCA1 or BRCA2 germline mutationsS Wang-Gohrke, W Weikel, H Risch, et al.
Journal of the National Cancer Institute|May 30, 1998
Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genesJ S Brunet, P Ghadirian, T R Rebbeck, et al.
Pharmacogenetics|October 23, 2001
Progesterone receptor variant increases ovarian cancer risk in BRCA1 and BRCA2 mutation carriers who were never exposed to oral contraceptivesI B Runnebaum, S Wang-Gohrke, D Vesprini, et al.
Nature Medicine|November 1, 1996
Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer familiesP Tonin, B Weber, K Offit, et al.
Pageof 25